386 related articles for article (PubMed ID: 23063971)
1. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Gastroenterology; 2013 Feb; 144(2):323-332. PubMed ID: 23063971
[TBL] [Abstract][Full Text] [Related]
2. Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.
Chang Y; Liu Q; Zhou Z; Ding Y; Yang M; Xu W; Chen K; Zhang Q; Wang Z; Li H
Technol Cancer Res Treat; 2020; 19():1533033820934881. PubMed ID: 32552476
[TBL] [Abstract][Full Text] [Related]
3. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
[TBL] [Abstract][Full Text] [Related]
4. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.
Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S
Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132
[TBL] [Abstract][Full Text] [Related]
5. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
Kim G; Jang SY; Nam CM; Kang ES
J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
[TBL] [Abstract][Full Text] [Related]
6. Statins use and risk of depression: a systematic review and meta-analysis.
Parsaik AK; Singh B; Murad MH; Singh K; Mascarenhas SS; Williams MD; Lapid MI; Richardson JW; West CP; Rummans TA
J Affect Disord; 2014 May; 160():62-7. PubMed ID: 24370264
[TBL] [Abstract][Full Text] [Related]
7. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
9. Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
Turk J Gastroenterol; 2022 Feb; 33(2):136-144. PubMed ID: 35115293
[TBL] [Abstract][Full Text] [Related]
10. Statins and primary liver cancer: a meta-analysis of observational studies.
Pradelli D; Soranna D; Scotti L; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Eur J Cancer Prev; 2013 May; 22(3):229-34. PubMed ID: 23010949
[TBL] [Abstract][Full Text] [Related]
11. Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis.
Li Z; Li Y; Li X; Zhang L; Zhao N; Du H; Zhou B; Ye Y
Medicine (Baltimore); 2018 Aug; 97(34):e11950. PubMed ID: 30142817
[TBL] [Abstract][Full Text] [Related]
12. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection.
Tsan YT; Lee CH; Wang JD; Chen PC
J Clin Oncol; 2012 Feb; 30(6):623-30. PubMed ID: 22271485
[TBL] [Abstract][Full Text] [Related]
13. Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.
Li X; Sheng L; Liu L; Hu Y; Chen Y; Lou L
BMC Gastroenterol; 2020 Apr; 20(1):98. PubMed ID: 32272891
[TBL] [Abstract][Full Text] [Related]
14. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
[TBL] [Abstract][Full Text] [Related]
15. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
[TBL] [Abstract][Full Text] [Related]
16. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
El-Serag HB; Johnson ML; Hachem C; Morgana RO
Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
[TBL] [Abstract][Full Text] [Related]
17. Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden.
Björkhem-Bergman L; Backheden M; Söderberg Löfdal K
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1101-6. PubMed ID: 25074765
[TBL] [Abstract][Full Text] [Related]
18. Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis.
Kim HW; Joo YS; Kang SC; Koh HB; Han SH; Yoo TH; Kang SW; Park JT
Sci Rep; 2022 Jun; 12(1):10807. PubMed ID: 35752695
[TBL] [Abstract][Full Text] [Related]
19. Impact of statin use on the risk and prognosis of hepatocellular carcinoma: a meta-analysis.
Wang J; Li X
Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1603-1609. PubMed ID: 33405428
[TBL] [Abstract][Full Text] [Related]
20. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]